Adoptively transferred tumor-specific T cells expanded ex vivo using HSV amplicons encoding 4-1BBL show increased anti-tumor activity in vivo

被引：0
|
作者：
Yi, Kyung H.
Nechushtan, Hovav
Zhang, Yu
Bowers, William J.
Federoff, Howard J.
Pham, Dien G.
Podack, Eckhard R.
Rosenblatt, Joseph D.
机构：
[1] Univ Miami, Miami, FL USA
[2] Univ Rochester, Rochester, NY USA
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4757
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Ex vivo expansion of tumor-draining lymph node cells using compounds which activate intracellular signal transduction .1. Characterization and in vivo anti-tumor activity of glioma-sensitized lymphocytes
    Baldwin, NG
    Rice, CD
    Tuttle, TM
    Bear, HD
    Hirsch, JI
    Merchant, RE
    JOURNAL OF NEURO-ONCOLOGY, 1997, 32 (01) : 19 - 28
  • [32] Ex vivo co-stimulatory 4-1BBL enhances the antitumor capacity of antigen specific CD8+T cells after adoptive transfer in NSG mice
    Srivastava, Abhishek
    Paria, Biman
    Chandran, Smita
    Kammula, Udai
    JOURNAL OF IMMUNOLOGY, 2015, 194
  • [33] T Cells engineered to express the IL-13Rα2 specific CAR and a PD-L1 specific switch receptor show increased anti-tumor activity in the Glioblastoma tumor microenvironment
    De Castro, Abel
    Keys, Megan E.
    Arroyo, Jonathan
    Prosser, Megan E.
    CANCER RESEARCH, 2018, 78 (13)
  • [34] HER2-targeting CAR-T cells show highly efficient anti-tumor activity against glioblastoma both in vitro and in vivo
    Li, Xueying
    Zhao, Lifen
    Li, Wenzhe
    Gao, Peng
    Zhang, Nianzhu
    GENES AND IMMUNITY, 2024, 25 (03) : 201 - 208
  • [35] In Vivo Anti-Tumor Effects of Citral on 4T1 Breast Cancer Cells via Induction of Apoptosis and Downregulation of Aldehyde Dehydrogenase Activity
    Nigjeh, Siyamak Ebrahimi
    Yeap, Swee Keong
    Nordin, Norshariza
    Rahman, Heshu
    Rosli, Rozita
    MOLECULES, 2019, 24 (18):
  • [36] Systemic β-Adrenergic Receptor Activation Augments the ex vivo Expansion and Anti-Tumor Activity of Vγ9Vδ2 T-Cells
    Baker, Forrest L.
    Bigley, Austin B.
    Agha, Nadia H.
    Pedlar, Charles R.
    O'Connor, Daniel P.
    Bond, Richard A.
    Bollard, Catherine M.
    Katsanis, Emmanuel
    Simpson, Richard J.
    FRONTIERS IN IMMUNOLOGY, 2020, 10
  • [37] AUTOLYMPHOCYTE THERAPY .1. IN-VIVO TUMOR-SPECIFIC ADOPTIVE CELLULAR THERAPY OF MURINE MELANOMA AND CARCINOMA USING EX-VIVO ACTIVATED MEMORY T-LYMPHOCYTES
    GOLD, JE
    OSBAND, ME
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (12) : 1871 - 1882
  • [38] In vivo anti-tumor efficacy of melanoma antigen-specific cytotoxic T lymphocytes generated using artificial antigen presenting cells (aAPC)
    Durai, Malarvizhi
    Krueger, Christine
    Ye, Zhaohui
    Cheng, Linzhao
    Mackensen, Andreas
    Oelke, Mathias
    Schneck, Jonathan
    JOURNAL OF IMMUNOLOGY, 2006, 176 : S257 - S257
  • [39] Ex vivo expansion of tumor-draining lymph node cells using compounds which activate intracellular signal transduction. I. Characterization and in vivo anti-tumor activity of glioma-sensitized lymphocytes
    Nevan G. Baldwin
    Charles D. Rice
    Todd M. Tuttle
    Harry D. Bear
    Jerry I. Hirsch
    Randall E. Merchant
    Journal of Neuro-Oncology, 1997, 32 : 19 - 28
  • [40] CS1-Specific Chimeric Antigen Receptor (CAR)-Engineered NK Cells and T Cells Enhance In Vitro and In Vivo Anti-Tumor Activity Against Human Multiple Myeloma
    Chu, Jianhong
    Deng, Youcai
    Benson, Don M., Jr.
    He, Shun
    Hughes, Tiffany L.
    Zhang, Jianying
    Peng, Yong
    Mao, Hsiaoyin
    Yi, Ling
    He, Xiaoming
    Devine, Steven M.
    Zhang, Xiaoliu
    Caligiuri, Michael A.
    Hofmeister, Craig C.
    Yu, Jianhua
    BLOOD, 2013, 122 (21)
12345